Theranostics - Cancer Treatment with Precision Medicine
-
Register
- Non-member - Free!
- Member - Free!
Tune to the APSHO Radiation Oncology APP Network for a webinar on Theranostics - Cancer Treatment with Precision Medicine by Jamie Raney, MBA, CNMT
- What is Theranostics? A high-level overview of Theranostics
- Programs of Excellence: What good looks like
- The Theranostics of Tomorrow: Innovations shaping the future
- Impact of Theranostics in Radiation Therapy
The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.
1. What is Theranostics? A High-Level Overview
- Define the concept of theranostics and explain its role in cancer treatment.
- Identify the key components and principles behind theranostic approaches.
- Describe the clinical applications and benefits of theranostics in cancer care.
2. Programs of Excellence: What Good Looks Like
- Analyze the characteristics of successful theranostic programs.
- Evaluate best practices for implementing theranostics in clinical settings.
3. The Theranostics of Tomorrow: Innovations Shaping the Future
- Explore emerging technologies and innovations driving theranostics forward.
- Predict potential future applications and trends in theranostic research.
- Assess the impact of AI, imaging, and molecular targeting on theranostics.
4. Impact of Theranostics in Radiation Therapy
- Explain how theranostics integrates with radiation therapy workflows.
- Assess the clinical outcomes and patient benefits of theranostic-guided radiation therapy.
- Discuss challenges and opportunities in combining theranostics with radiotherapy.
Jamie Raney, MBA, CNMT
Care Pathway Leader for Theranostics Strategy and Growth
GE Healthcare
Jamie Raney is a seasoned healthcare executive with over two decades of experience in nuclear medicine, theranostics, and imaging operations. Currently serving as the Care Pathway Leader for Theranostics Strategy and Growth at GE HealthCare, Jamie partners with providers across the U.S. and Canada to enable and optimize cutting-edge theranostics programs that elevate patient care and operational efficiency.
Jamie's career spans leadership roles in both clinical and corporate settings, including as Regional Director of Operations at CDL Nuclear Technologies, Director of Imaging and Nuclear Medicine for Rocky Mountain Cancer Centers, and as Practice Administrator at BAMF Health, where he launched the clinical operations of a state-of-the-art Theranostics Center. His expertise also includes consulting for a national radiopharmacy network and serving as a Medical Science Liaison for Telix Pharmaceuticals, where he provided support in the pre-launch of illuccix as well as the research pipeline.
With a strong foundation in nuclear medicine technology and a Master of Business Administration in Healthcare Management, Jamie brings a unique blend of clinical insight and strategic acumen. He is a Certified Nuclear Medicine Technologist and an active member of the Society of Nuclear Medicine and Molecular Imaging.
Jamie is passionate about advancing theranostics and molecular imaging to improve outcomes for patients and communities. His leadership is marked by a commitment to operational excellence, innovation, and collaborative growth.
Disclosure: Jamie Raney is the Theranostics Strategy & Growth Care Pathway Leader for the GE HealthCare overseeing United States and Canada.
Key:
Complete
Next
Failed
Available
Locked